chrisvoncsefalvay/vaers-outcomes huggingface dataset:
itching on right side of abdomen near liver and gallbladder followed by pale/light colored stools on day 2 and 3 so far
CT reports redness, swelling, pain, itching in right shoulder/deltoid where vaccine given, also reports pain radiating to right elbow and numbness and tingling in fingers of right hand.
Uncontrollable shaking, freezing, followed by fever, muscle/bone pain, ongoing bronchial cough. Have taken regular flu shots since they were available with no bad effects. What medical moron thought giving a Sr. 400% more powerful vaccine was a good idea? Oh, yes! I had shot and walked to front of store. Was overcome by a horrible dizzy spell. No longer than 2 mins. following receipt of shot.
Patient received booster vaccine Pfizer with the lot #FG3527 and expiration date 02/2022 and vaccine has been stored in the refrigerator and should have been used  until 12/12/2021 and patient received the vaccine on 12/13/2021 , as a result the vaccine could be considered expired for one day. However , patient has not experienced any side effects.
Patient developed Herpes Zoster on his face.  It was mild and treated appropriately.  It occurred two days after the Influenza vaccine was administered.
Redness and swelling at injection site, itching. Cool compresses and Tylenol.
Immediately following the vaccines pt. became very hypotonic and acted as he had an absence seizure.  Vitals obtained and all normal.  After a couple of minutes he did start to interact with his mom.  MD called into the room.  Physical exam completed with all normal neurological assessments.  He did continueto act "very tired".  He raimed in the office for 40 minutes after the episode.  He was then cleared to go home by the MD.
Patient received first dose of vaccine 5/10, second dose administered 6/7.  6/8 patient presented to ER with complaints of Malaise and fatigue, found with mild altered mental status and eventually had to be intubated
SEVERE BLEEDING; CRAMPING FOR SIX DAYS; RECEIVED PERIOD 10 DAYS EARLY; SPOTTING ON THE FIRST DAY; BODY ACHES; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On SEP-2021, the patient experienced severe bleeding. On SEP-2021, the patient experienced cramping for six days. On SEP-2021, the patient experienced received period 10 days early. On SEP-2021, the patient experienced spotting on the first day. On SEP-2021, the patient experienced body aches. On SEP-2021, the patient experienced nausea. On SEP-2021, the patient experienced fatigue. The action taken with covid-19 vaccine was not applicable. The patient recovered from body aches, nausea, and fatigue on SEP-2021, and had not recovered from severe bleeding, cramping for six days, received period 10 days early, and spotting on the first day. This report was non-serious.
Pt recvd 1 dose of engerix & 26JUN92 (8 days later) exp hives, rash on head/hands/feet/arms/back of legs, raised areas, erythema;
felt like she was burning up; was soaking wet; dry heaving; aches and pains like a really bad flu; horrible, pounding headache; vomiting a little; fever with temperature readings of 99, 101, 103, and 103.5; arm is a little swollen around the injection site; lymph nodes swollen in both arms; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (felt like she was burning up), HYPERHIDROSIS (was soaking wet), RETCHING (dry heaving), PAIN (aches and pains like a really bad flu) and HEADACHE (horrible, pounding headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included LEVOTHYROXINE and LOSARTAN for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced FEELING HOT (felt like she was burning up), HYPERHIDROSIS (was soaking wet), RETCHING (dry heaving), PAIN (aches and pains like a really bad flu), HEADACHE (horrible, pounding headache), VOMITING (vomiting a little), PYREXIA (fever with temperature readings of 99, 101, 103, and 103.5), VACCINATION SITE SWELLING (arm is a little swollen around the injection site) and LYMPHADENOPATHY (lymph nodes swollen in both arms). On 29-Apr-2021, FEELING HOT (felt like she was burning up), HYPERHIDROSIS (was soaking wet), RETCHING (dry heaving), PAIN (aches and pains like a really bad flu), HEADACHE (horrible, pounding headache), VOMITING (vomiting a little) and PYREXIA (fever with temperature readings of 99, 101, 103, and 103.5) had resolved. At the time of the report, VACCINATION SITE SWELLING (arm is a little swollen around the injection site) and LYMPHADENOPATHY (lymph nodes swollen in both arms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Apr-2021, Body temperature: 99 (High) 99, 101 (High) 101, 103 (High) 103 and 103.5 (High) 103.5.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up received on 04-JUN-2021, Patient demography updated, reporter details updated, 1st dose date corrected.
Pt developed redness, swelling and pain at injection site. She was determined to have cellulitis and recovered quickly after starting Keflex.
injection site swelling, Body rash, eczema type eruptions in multiple sites over body, itching, scaling
Approximatey 1hr after the vaccination, c/o of feeling internal itching all over but under the skin at 4:30.  An hr later c/o "flu like symptoms e.g. aches and pains, then had to take a nap.  Woke up the next morning c/o soarness, itching, and self-administred Zyrtec 1 po in a.m then again in the p.m.  Felt some relief but a little achey just flu-like.  Most of Sunday felt the same but Sunday approx 6p broken out into red whelts on the chest and back, throat felt like it was starting to close in and I went to the ER at approximately 8 p.m.  Was given Prednasone 10 day pack, and Benadryl  both p.o.  Did receive somewhat relief from the Rx.  Nothing was done to airway.  Continues to c/o itching underneath the skin
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Fever-Medium, Systemic: SWELLING RIGHT FOOT, KIDNEY PAIN-Severe, Systemic: Hypertension-Severe, Additional Details: .
Approx 1 inch in diameter pink raised area noted back of right upper arm where student states chicken pox vaccine was injected. both student and mom state noticed last night, deny other problems. Student states it itches now that he noticed it.
Second vaccine administered less than 21 days; Mixed series vaccinations administered; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccine administered less than 21 days) and INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccinations administered) in a 3-week-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer Covid-19 vaccine on 09-Sep-2021.    On 13-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccine administered less than 21 days) and INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccinations administered). On 13-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second vaccine administered less than 21 days) and INTERCHANGE OF VACCINE PRODUCTS (Mixed series vaccinations administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  It was reported that the gave the pharmacist gave Moderna COVID-19 vaccine on 13-Sep-2021 to a patient who was at the pharmacy asking for their flu vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: Follow-up received and does not contain any new information.
Allergic reaction, itchiness all over the body.  I received my first vaccine on Feb 20th and two weeks after (March 3rd) I started getting itchy and tiny bumps all around my body except the area where I received the vaccine. The itchiness will be random, from calf to fore arm to armpit to back (bra line) to hip to hands (between fingers).
diagnosed with having the Covid; This is a spontaneous report from a Pfizer sponsored program. A non-contactable consumer reported a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient had the first dose of the COVID vaccine on Sunday (date unspecified). On Wednesday (date unspecified), patient started to feel badly. Yesterday, patient was diagnosed with having the COVID.  The reporter wanted to know if this person is safe at all. Outcome of events was unknown.   Information on the lot/batch number has been requested.
tingling in face and all over Funny Feeling, dizziness No txment. Vitals taken, observation, legs elevated  Allergy Review recommended 1/18/21 Allergy evaluation -> adverse reaction not  allergic - cleared for 2nd vaccine with hydration,  eat breakfast, monitor for 60 min after vaccine Received 2nd vaccine 1/19/2021
Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Mar2021 (Lot number: EN6198) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Immunocompromised" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache".  No follow-up attempts are possible. No further information is expected.
TSH level increased, Hashimotos flare up,.Cervical arthritis flare up causing pain. Need to go to physical therapy. May need steroid injections for neck pain. Constant stomach pains. LPR reflux has returned, unable to control, was under control.   Lightheaded,loss of balance, blurred vision, headaches, tingling and numbness right hand and fingers, and right foot. Weight gain, tired, exhaustion. These all started around March 17th and continue to get worse.  Vitamin deficiencies.
This spontaneous report was received from a medical assistant and refers to 2 patients of unknown age and gender. There was no information regarding the patients' pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 30-AUG-2016, the patients were vaccinated with improperly stored doses of VARIVAX (lot # M012991, expiration date 14-MAR-2018, site, doses and route of administration were not reported). No adverse effects were reported. This is one of two reports received from the same source. Additional information is not expected due to lack of the reporter's contact details.
another doctor who recently treated a female patient with the same symptoms who was test for Shingles and tested positive; this person also received the Pfizer COVID 19 vaccine in the same time frame; This is a spontaneous report from a contactable consumer or other non hcp.    A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19, Solution for injection, lot number: unknown), via an unspecified route of administration, administered in Arm Right on 23Apr2021 12:00 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported.  The patient's concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19, Solution for injection; Lot number: unknown), via an unspecified route of administration on 02Apr2021 12:00 administered in left arm as single dose for COVID-19 immunisation. The patient experienced another doctor who recently treated a female patient with the same symptoms who was test for shingles and tested positive; this person also received the pfizer covid 19 vaccine in the same time frame on 2021.  The patient underwent lab tests and procedures which included herpes zoster: positive on 2021. The outcome of event was unknown.
Patient was crying inconsolably for 2 week or more immediately after vaccines were given. She broke out in rough, dry, red, inflammed rash all over her head and body within a week to two weeks after vaccines were given. Patient was taken back to the pediatrician on 3/13/2018 and diagnosed with eczema.
Some normal pain at injection site. (Time was incorrect on previous question - according to pharmacy receipt, I received the SHINGRIX immunization at 5:16 PM - I'm not sure if I can go back and change it on this form). Primary reason for report is red flat rash that developed approximately 48 hours later just below the injection site. Spread towards shoulder and became itchy the next morning, remained flat and disappeared in 4 days. I never developed any blisters and the rash remained flat and mildly itchy, relieved by hydrocortisone cream. I did not see my doctor or report it to the pharmacy.
The pain has been excruciating especially since she received the Covid-19 vaccine; This is a spontaneous report from a contactable consumer. This consumer reported for his mother. A 79-year-old female patient first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EM9809) via an unspecified route of administration, administered in arm right on 06Feb2021 (at age of 79-years) as dose 1, single for covid-19 immunisation (covid prevention) at hospital. The patient medical history included ongoing acute rheumatoid arthritis (being treated for rheumatoid arthritis, taking prednisone and steroid shots in her shoulder). The patient's concomitant medications were a list of medications and infusions of prednisone and another steroid injection (gets the steroid shot every 3 months) both for acute rheumatoid arthritis from unspecified date to 05Feb2021. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. There were no prior vaccinations within 4 weeks and no illness at time of vaccination. Reportedly, the patient had to go off her medication prior to receiving the first Pfizer Covid-19 vaccination on 06Feb2021. The patient 's HCP stopped her prednisone and another steroid injection on the 05Feb2021 and stated, "they took her off her infusions and it's been getting worse and worse." The patient has been having pain in Feb2021 (since being off her medication). The patient was in extreme pain from not having her other meds and the pain had been excruciating especially since she received the Covid-19 vaccine and pain started on 09 or 10Feb2021. She had to get a TORADOL shot for pain (as therapeutic measure). She was seen at the Urgent Care and at the physician's office. The patient was also off her rheumatoid arthritis medications for a year while the doctors were trying to figure out what to start her on and it had been getting worse and worse. On 16Feb2021 she was started on ORICA infusions and the rheumatologist said she should be on this medication and there should be no issues with her getting the shot. She visited the physician office for pain. The patient's second Pfizer Covid-19 vaccine was scheduled 27Feb2021 and steroid shot (in left arm for left and right shoulder) on the 23Feb2021 and the 04Mar2021. No other products administered. She understood that she was unable to have more than 5mg at a balanced rate and no prednisone for 2 weeks after the injection and she was also not able to receive the steroid shots. There were no relevant tests. Reportedly, the case was non-serious. The outcome of event was unknown.  No follow-up attempts were possible. No further information was expected.
Initial information received on 15-Oct-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a four years old patient (gender not reported) who was vaccinated with a 0.5 ml dose of QUADRACEL (lot C5447AA and Exp date 18 Oct 2019) via unknown route in the right deltoid on 28-Sep-2018 a component of the PENTACEL instead of having both vials reconstituted and administered together. The patients medical history and concomitant medications were not reported. Concomitant medications included MMR for Immunisation; and VARICELLA VACCINE for Immunisation. It was an actual medication error due to inappropriate reconstitution technique. No information about any adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Information has been received from a nurse concerning a 17 years old patient of unknown gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 18-JAN-2017, the patient was vaccinated with a dose of improperly stored GARDASIL 9 (lot # M024261, expiration date, dose and route unknown) for prophylaxis. The vaccines were stored at 11.6 degree centigrade for 1 hour and 50 minutes. Data logger was involved in the case. There was previous temperature excursion at 9.3 degree centigrade for 50 minutes. No adverse effect was reported. It was reported that the excursion involved a total of three lots of GARDASIL 9. Two lots (L024993 and M024261) were involved in the event "doses of GARDASIL 9 administered after 13-DEC-2016 temperature incident". This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA008047: US-009507513-1612USA007442: US-009507513-1703USA002792: US-009507513-1703USA002793: US-009507513-1703USA002794: US-009507513-1703USA002795: US-009507513-1703USA002797: US-009507513-1703USA002798: US-009507513-1703USA002799: US-009507513-1702USA010448:
Patient reported no contraindications at the time of prescreening  and received vaccine around 1.35pm. Around 1.38pm, patient reported of feeling dizzy, BP was taken 110/71 mmHg, at 1.46pm BP was 96/67 mmHg, at 1.57pm BP was 109/73 mmHg. After drinking water patient reported of feeling much better.
GRAPEFRUIT SIZED AREA OF ERYTHEMA TO LEFT LEG AT INJECTION SITE AND LATERAL TO INJECTION SITE. MINIMAL TENDERNESS, NOT WARM TO TOUCH.
About one week later, I started to feel sick, tired and started with my problems with digestion, colitis which I already had before. I could not eat anything and digest anything that is why I went to the doctor. I started to notice also a ball-like lump on my left axilla which upon palpation was tender. I took OTC Tylenol for relief of pain. The ball on my left axilla lasted few days then resolved. I have history of varicose veins and a I also noticed a ball-like lump on my right and left knee. My feet hurt throughout the day and upon palpation the ball-lime lump on my knee also hurts. The doctor I saw by the name of doctor said the ball-like lump was part of circulation problems I have, due to my varicose veins. I was told to do exercise and rest and it would go away and also to drink more water and fruits. I will have lab work scheduled for 07-29-2021. I continue with the ball-like lump on my right and left knee that when touching it, it hurts.
On 03/08/2002 left upper arm swollen, red, hard from shoulder to elbow. Instructed mom to take child to ER if the arm gets any worse. Told to give Tylenol and cool compress. Parent stated child's arm was better without any swelling and redness on 03/11/2002.
Injection arm restricted mobility for 2 days after shot, fatigue and general feeling of illness day after shot, hypersensitivity of skin on back, shoulders, and underarms that started a week after the injection
Starting in July, middle of normal 4 mile run, pain in left thigh, could not walk.  August while hiking in mountains, 3/4 finished could not walk pain left thigh.  Later reduced and could walk run.  Sept. pain returned could not bend left eg or put weight on it.  Doing P.T. and pain reducing
Auto-immune symptoms, Raynaud's, arthritis, pneumonia, granulomas, skin lesions, fatigue, fever.
Follow-up information from the physician provided patient's birth weight, changes to concurrent illness and concomitant medication, and event outcome (recovery pending). Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal solution (frozen) was received from a mother regarding her 4-year-old daughter who experienced nasal congestion a few days post-immunization. The patient received a dose on 18-Dec-2003. Medical history: The patient has a past history of acute purulent otitis media. The patient's concurrent illnesses include otitis media and upper respiratory infection. Product details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 18-Dec-2003. Dose regimen was 0.5 mL (intranasal). Concomitant Therapy: Concomitant therapy included Augmentin (amoxicillin sodium/clavulante potassium) and no other vaccines. Event details: A few days post-immunization with Flumist, the child experienced nasal congestion. The physician reported that recovery is "pending."
Pt reports pain at injection site spreading to other shoulder, bilateral arms and hands, abdomen, down spine and in legs. Couldn't move due to pain. Couldn't open fingers. St's it's the worst pain he has ever felt.